Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well-Controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of cART

NCT01384682 is registered in ClinicalTrials.gov with Kirby Institute as lead sponsor.

NCT NCT01384682
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01384682 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomised, Openlabel Study Evaluating Efficacy and Safety of Maraviroc as a Switch for Either NRTI or PI/r in HIV-1 Infected Individuals With Stable, Well-Controlled Plasma HIV-RNA While Taking Their First N(t)RTI + PI/r Regimen of cART
Lead sponsor
Kirby Institute
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2011
Completion date
December 31, 2015
Enrollment
399 (actual)
Sites
51

Conditions

As the registry lists them; a condition with its own page is linked.

hiv